by Clinical Neuropsychologist Online | Thursday, August 6, 2026 | Neurorehabilitation
. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | August 6, 2026 Neuro-Rehab Previous Page
by Clinical Neuropsychologist Online | Thursday, August 6, 2026 | Neurorehabilitation
. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | August 6, 2026 Neuro-Rehab Previous Page
by Clinical Neuropsychologist Online | Thursday, August 6, 2026 | Dementia
Abstract INTRODUCTION We evaluated lecanemab’s safety and cognitive outcomes in Chinese patients with Alzheimer’s disease (AD) and the utility of blood-based biomarkers (BBMs) for treatment guidance. METHODS A multicenter, real-world cohort enrolled 1042...
by Clinical Neuropsychologist Online | Thursday, August 6, 2026 | Neuropsychology (general)
. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | August 6, 2026 Neuro-General Previous Page
by Clinical Neuropsychologist Online | Thursday, August 6, 2026 | Neuroscience
Nature Neuroscience, Published online: 06 August 2026; doi:10.1038/s41593-026-02397-8This study finds that shed NLGN3 interacts with the glycosylated surface protein CSPG4 on both normal and malignant glial cells, activating mechanotransduction pathways that drive...